Tumour Volume
Showing 51 - 75 of 9,004
PET-imaging in Squamous Cell Carcinoma Located in Head and Neck
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Intensity Modulated Proton Therapy (IMPT) +/- Chemotherapy
-
Delft, Zuid-Holland, NetherlandsHolland Proton Therapy Centre (HollandPTC)
Apr 1, 2022
TGCT Trial in Washington, Baltimore (Emactuzumab, Placebo)
Active, not recruiting
- TGCT
- Emactuzumab
- Placebo
-
Washington, District of Columbia
- +1 more
Sep 23, 2022
Hepatocellular Carcinoma, Portal Vein Tumour Thrombosis Trial in Canada (Neoadjuvant)
Recruiting
- Hepatocellular Carcinoma
- Portal Vein Tumour Thrombosis
- Neoadjuvant
-
Calgary, Alberta, Canada
- +6 more
Oct 18, 2022
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
Malignant Pleural Mesothelioma Trial (Proton beam therapy)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Proton beam therapy
- (no location specified)
Dec 14, 2022
Glioblastoma Multiforme Trial in Manchester (Preoperative brain irradiation (single fraction))
Recruiting
- Glioblastoma Multiforme
- Preoperative brain irradiation (single fraction)
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Aug 2, 2022
Hepatocellular Carcinoma, Scirrhous, Recurrence Tumor Trial in Lisboa (liver transplant)
Recruiting
- Hepatocellular Carcinoma, Scirrhous
- Recurrence Tumor
- liver transplant
-
Lisboa, PortugalCentro Hepato-bilio-pancreático e de Transplantação do Hospital
Jun 3, 2022
Oncology Trial in Nijmegen (combined aerobic exercise + resistance exercise intervention (AE + RE), Aerobic exercise prior to
Recruiting
- Oncology
- combined aerobic exercise + resistance exercise intervention (AE + RE)
- Aerobic exercise prior to daily radiotherapy sessions (ExPR)
-
Nijmegen, Gelderland, NetherlandsRadboud Institute for Health Science
Jan 8, 2023
Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)
Active, not recruiting
- Melanoma
- Dabrafenib
- +2 more
-
Sydney, New South Wales, Australia
- +2 more
Apr 4, 2022
Rectal Tumors Trial in Mumbai (Chlorophyllin, Sodium Copper Complex, Placebo)
Not yet recruiting
- Rectal Neoplasms
- Chlorophyllin, Sodium Copper Complex
- Placebo
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
May 3, 2023
Advanced Solid Tumours Trial in United States (AZD9150, Durvalumab, Cisplatin)
Active, not recruiting
- Advanced Solid Tumours
- AZD9150
- +6 more
-
Lafayette, Indiana
- +5 more
Jul 22, 2022
Pancreatic Cancer, Endoscopic Ultrasound Trial in Hong Kong (EUS-guided oncosil injection)
Recruiting
- Pancreatic Cancer
- Endoscopic Ultrasound
- EUS-guided oncosil injection
-
Hong Kong, Hong KongDepartment of Surgery, Prince of Wales Hospital
Nov 22, 2021
A Human Versus Machine Comparison Study
Recruiting
- Head and Neck Cancer
-
Northwood, UK, United KingdomEast & North Hertfordshire NHS Trust
Sep 15, 2023
Primary Aldosteronism, Aldosterone-Producing Adenoma Trial in Bergen (EUS-RFA of left adrenal gland, adrenalectomy)
Recruiting
- Primary Aldosteronism
- Aldosterone-Producing Adenoma
- EUS-RFA of left adrenal gland
- adrenalectomy
-
Bergen, NorwayHaukeland University Hospital
Aug 15, 2022
Invasive Margin of Glioblastomas (PRaM-GBM Study)
Active, not recruiting
- High Grade Glioma
- Diffusion tensor Imaging (DTI)
-
Cambridge, United KingdomCambridge University Hospitals NHS Foundation Trust
Dec 29, 2021
Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +5 more
- Re-irradiation
- (no location specified)
Oct 16, 2023
Brain Imaging to Predict Toxicity in Elderly Patients After
Completed
- Glioblastoma Multiforme, Adult
- +2 more
- MRI scans and questionnaires
-
Brighton, Sussex, United KingdomScott Harfield
Jan 3, 2023
Breast Cancer Trial in United Kingdom (Hydrogen Peroxide)
Recruiting
- Breast Cancer
- Hydrogen Peroxide
-
Lucknow, Uttar Pradesh, India
- +7 more
Sep 21, 2022
Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)
Terminated
- Renal Cell Carcinoma (RCC)
- Chimeric monoclonal antibody cG250
- Sunitinib malate
-
Heidelberg, Victoria, AustraliaAustin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Melbourne (177Lu-PSMA)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Mar 28, 2022
Cerebral Morbidity After Radiation Therapy for Brain Tumors
Active, not recruiting
- Brain Tumor
- +2 more
- Cognitive tests and Patient Reported Outcome
-
Copenhagen, Region H, Denmark
- +3 more
May 4, 2021
NSCLC/Oligometastatic Cancer (Single Lung Lesion) Trial in Dublin (Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR))
Recruiting
- NSCLC/Oligometastatic Cancer (Single Lung Lesion)
- Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)
-
Dublin, Ireland
- +1 more
Feb 11, 2022
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Surufatinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 20, 2023
Rectal Cancer Trial in Montpellier (Biological collection)
Recruiting
- Rectal Cancer
- Biological collection
-
Montpellier, Hérault, FranceInsitut Régional du Cancer de Montpellier
Jun 16, 2021